Fortrea Holdings (FTRE) Other Non Operating Income (2022 - 2026)
Fortrea Holdings (FTRE) reported Other Non Operating Income of $500000.0 for Q1 2026, down 98.61% quarter-over-quarter from $36.0 million in Q4 2025.
Fortrea Holdings (FTRE) Other Non Operating Income (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Other Non Operating Income for 5 years, with the latest figure at $500000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income changed N/A year-over-year to $500000.0; the trailing twelve-month figure through Mar 2026 stood at $14.0 million (down 47.37% YoY), and the FY2025 full-year result was $7.9 million, down 62.91% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $500000.0, down from $36.0 million in the prior quarter.
- The five-year high for Other Non Operating Income was $36.0 million in Q4 2025, with the low at -$23.1 million in Q4 2022.
- Historically, Other Non Operating Income has averaged $1.3 million across 5 years, with a median of -$200000.0 in 2024.
- Annual changes were most pronounced in 2024 — Other Non Operating Income jumped 758.14% — and 2025, when it tumbled 1226.67%.
- Fortrea Holdings' Other Non Operating Income stood at -$23.1 million in 2022, then soared by 81.39% to -$4.3 million in 2023, then jumped by 758.14% to $28.3 million in 2024, then grew by 27.21% to $36.0 million in 2025, then sank by 98.61% to $500000.0 in 2026.
- The last three Other Non Operating Income figures came in at $500000.0 (Q1 2026), $36.0 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 36.00 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | -19.90 Mn |
| Dec 31, 2024 | 28.30 Mn |
| Sep 30, 2024 | -200,000.00 |
| Jun 30, 2024 | -1.50 Mn |
| Mar 31, 2024 | -5.30 Mn |
| Dec 31, 2023 | -4.30 Mn |
| Sep 30, 2023 | -1.20 Mn |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | -23.10 Mn |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 12.00 Mn |